These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34041623)

  • 1. Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome.
    Li J; Nelis M; Sourbron J; Copmans D; Lagae L; Cabooter D; de Witte PAM
    Neurochem Res; 2021 Sep; 46(9):2249-2261. PubMed ID: 34041623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of fenfluramine in clinical practice: Pharmacokinetic variability and impact of concomitant antiseizure medications.
    Schoonjans AS; Roosens L; Dewals W; Paelinck BP; Ceulemans B
    Epilepsia; 2022 Mar; 63(3):686-696. PubMed ID: 35032026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
    Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
    PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized treatment approaches: Fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome.
    Polster T
    Epilepsy Behav; 2019 Feb; 91():99-102. PubMed ID: 30269941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.
    Cha J; Filatov G; Smith SJ; Gammaitoni AR; Lothe A; Reeder T
    Epilepsia Open; 2024 Feb; 9(1):300-313. PubMed ID: 38018342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
    Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
    Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy.
    Pigliasco F; Cafaro A; Barco S; Stella M; Mattioli F; Riva A; Mancardi MM; Lattanzi S; Bandettini R; Striano P; Cangemi G
    J Pharm Biomed Anal; 2024 Aug; 245():116174. PubMed ID: 38703746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats.
    Erenburg N; Hamed R; Shaul C; Barasch D; Perucca E; Bialer M
    Epilepsia; 2024 Feb; 65(2):e14-e19. PubMed ID: 38041575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.
    Schoonjans A; Paelinck BP; Marchau F; Gunning B; Gammaitoni A; Galer BS; Lagae L; Ceulemans B
    Eur J Neurol; 2017 Feb; 24(2):309-314. PubMed ID: 27790834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenfluramine below the age of 2 years in Dravet syndrome: What about safety and efficacy?
    Pietrafusa N; Trivisano M; Casellato S; Correale C; Cappelletti S; De Liso P; Onida I; Sotgiu S; Butera A; Specchio N; Vigevano F
    Epilepsia; 2024 Feb; 65(2):e7-e13. PubMed ID: 38065833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is
    Erenburg N; Perucca E; Bechard J; Dube C; Weishaupt N; Sherrington R; Bialer M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta-analysis.
    Zhang L; Li W; Wang C
    Acta Neurol Scand; 2021 Apr; 143(4):339-348. PubMed ID: 33336426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
    Strzelczyk A; Pringsheim M; Mayer T; Polster T; Klotz KA; Muhle H; Alber M; Trollmann R; Spors H; Kluger G; Kurlemann G; Schubert-Bast S
    Epilepsia; 2021 Oct; 62(10):2518-2527. PubMed ID: 34378197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison.
    Devi N; Madaan P; Asrar MM; Sahu JK; Bansal D
    Seizure; 2021 Oct; 91():316-324. PubMed ID: 34274891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment.
    Bishop KI; Isquith PK; Gioia GA; Knupp KG; Scheffer IE; Nabbout R; Specchio N; Sullivan J; Auvin S; Helen Cross J; Guerrini R; Farfel G; Galer BS; Gammaitoni AR
    Epilepsy Behav; 2023 Jan; 138():108994. PubMed ID: 36463826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions.
    Martin P; Czerwiński M; Limaye PB; Ogilvie BW; Smith S; Boyd B
    Pharmacol Res Perspect; 2022 Jun; 10(3):e00959. PubMed ID: 35599347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective gas chromatographic assay with electron-capture detection for dl-fenfluramine and dl-norfenfluramine in plasma.
    Srinivas NR; Hubbard JW; Cooper JK; Midha KK
    J Chromatogr; 1988 Dec; 433():105-17. PubMed ID: 3235539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome.
    Schoonjans AS; Ceulemans B
    Expert Rev Neurother; 2022 May; 22(5):351-364. PubMed ID: 33455486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model.
    Sourbron J; Schneider H; Kecskés A; Liu Y; Buening EM; Lagae L; Smolders I; de Witte P
    ACS Chem Neurosci; 2016 May; 7(5):588-98. PubMed ID: 26822114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.